- Home
- CLDX vs GDRX Comparison
CLDX vs GDRX Comparison
Compare CLDX & GDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDX
- GDRX
- Stock Information
- Founded
- CLDX 1983
- GDRX 2011
- Country
- CLDX United States
- GDRX United States
- Employees
- CLDX N/A
- GDRX N/A
- Industry
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- GDRX Retail: Computer Software & Peripheral Equipment
- Sector
- CLDX Health Care
- GDRX Technology
- Exchange
- CLDX Nasdaq
- GDRX Nasdaq
- Market Cap
- CLDX 1.6B
- GDRX 1.7B
- IPO Year
- CLDX 2008
- GDRX 2020
- Fundamental
- Price
- CLDX $23.78
- GDRX $4.57
- Analyst Decision
- CLDX Buy
- GDRX Buy
- Analyst Count
- CLDX 7
- GDRX 15
- Target Price
- CLDX $64.83
- GDRX $8.75
- AVG Volume (30 Days)
- CLDX 1.1M
- GDRX 1.3M
- Earning Date
- CLDX 02-24-2025
- GDRX 02-27-2025
- Dividend Yield
- CLDX N/A
- GDRX N/A
- EPS Growth
- CLDX N/A
- GDRX N/A
- EPS
- CLDX N/A
- GDRX N/A
- Revenue
- CLDX $9,976,000.00
- GDRX $790,385,000.00
- Revenue This Year
- CLDX N/A
- GDRX $7.89
- Revenue Next Year
- CLDX N/A
- GDRX $4.04
- P/E Ratio
- CLDX N/A
- GDRX N/A
- Revenue Growth
- CLDX 128.55
- GDRX 7.14
- 52 Week Low
- CLDX $22.17
- GDRX $4.09
- 52 Week High
- CLDX $53.18
- GDRX $9.26
- Technical
- Relative Strength Index (RSI)
- CLDX 41.99
- GDRX 50.35
- Support Level
- CLDX $22.17
- GDRX $4.12
- Resistance Level
- CLDX $29.05
- GDRX $4.57
- Average True Range (ATR)
- CLDX 1.57
- GDRX 0.22
- MACD
- CLDX -0.26
- GDRX 0.03
- Stochastic Oscillator
- CLDX 23.40
- GDRX 71.65
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.
About GDRX GoodRx Holdings Inc.
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.